GI
FHTX icon

GAMMA Investing’s Foghorn Therapeutics FHTX Stock Holding History

GAMMA Investing’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.1K Sell
635
-229
-27% -$1.02K ﹤0.01% 3638
2026
Q1 		$4.13K Buy
864
+500
+137% +$2.75K ﹤0.01% 3433
2025
Q4 		$1.97K Buy
364
+109
+43% +$494 ﹤0.01% 3602
2025
Q3 		$1.25K Buy
+255
New +$1.35K ﹤0.01% 3564
2025
Q2 		– Sell
-96
Closed -$350 – 3818
2025
Q1 		$350 Sell
96
-15
-14% -$68 ﹤0.01% 3722
2024
Q4 		$524 Buy
+111
New +$809 ﹤0.01% 3566

Other funds holding FHTX

DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return

GAMMA Investing's FHTX Position: Q2 2026 in Review

GAMMA Investing reduced its Foghorn Therapeutics (FHTX) stake by 27% in Q2 2026, selling an estimated $1.02K and leaving 635 shares worth $3.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3638.

GAMMA Investing first reported a position in FHTX in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.13K in Q1 2026. 7 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • GAMMA Investing held 635 shares of Foghorn Therapeutics worth $3.1K as of Q2 2026.
  • GAMMA Investing sold 229 Foghorn Therapeutics shares in Q2 2026, an estimated $1.02K.
  • Foghorn Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3638 holding.
  • GAMMA Investing first reported a position in Foghorn Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • GAMMA Investing's Foghorn Therapeutics position peaked at $4.13K in Q1 2026.
  • 7 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.